Beam Therapeutics EPS Diluted from Extraordinaries (Quarterly) Trends

Beam Therapeutics, Inc. (BEAM)

27.21 -0.67 (-2.40%) USD | NASDAQ | Feb 20, 10:51

View EPS Diluted from Extraordinaries (Quarterly) for BEAM.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Extraordinaries (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Extraordinaries (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Extraordinaries (Quarterly) Benchmarks

Start Trial

Twist Bioscience Corp.	--
Intellia Therapeutics, Inc.	--
Pacific Biosciences of California, Inc.	--
Regeneron Pharmaceuticals, Inc.	--
Ionis Pharmaceuticals, Inc.	--